Cargando…
SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes
The emergence of resistance to antiviral drugs increasingly used to treat SARS-CoV-2 infections has been recognised as a significant threat to COVID-19 control. In addition, some SARS-CoV-2 variants of concern appear to be intrinsically resistant to several classes of these antiviral agents. Therefo...
Autores principales: | Fong, Winkie, Rockett, Rebecca J., Agius, Jessica E., Chandra, Shona, Johnson-Mckinnon, Jessica, Sim, Eby, Lam, Connie, Arnott, Alicia, Gall, Mailie, Draper, Jenny, Maddocks, Susan, Chen, Sharon, Kok, Jen, Dwyer, Dominic, O’Sullivan, Matthew, Sintchenko, Vitali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165565/ https://www.ncbi.nlm.nih.gov/pubmed/37158832 http://dx.doi.org/10.1186/s12879-023-08236-6 |
Ejemplares similares
-
SARS-CoV-2 Within-Host and in vitro Genomic Variability and Sub-Genomic RNA Levels Indicate Differences in Viral Expression Between Clinical Cohorts and in vitro Culture
por: Agius, Jessica E., et al.
Publicado: (2022) -
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
por: Rockett, Rebecca, et al.
Publicado: (2022) -
Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance
por: Rockett, Rebecca J., et al.
Publicado: (2022) -
Added Value of Genomic Surveillance of Virulence Factors in Shiga Toxin-Producing Escherichia coli in New South Wales, Australia
por: Sim, Eby M., et al.
Publicado: (2021) -
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
por: Basile, Kerri, et al.
Publicado: (2022)